Recent News for PIRS - Pieris Pharmaceuticals, Inc.

Date	Title
Aug 19	Pieris Pharmaceuticals Second Quarter 2024 Earnings: US$2.76 loss per share (vs US$3.63 profit in 2Q 2023)
Aug 17	We're A Little Worried About Pieris Pharmaceuticals' (NASDAQ:PIRS) Cash Burn Rate
Jul 24	Crude Oil Gains 1%; AT&T Shares Rise After Q2 Earnings
Jul 24	Pieris Pharma surges on all-stock merger deal
Jul 24	Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement
May 9	Looking Into Pieris Pharmaceuticals's Recent Short Interest